| College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer AC Wolff, ME Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ... J clin oncol 25 (1), 118-145, 2007 | 4995 | 2007 |
| College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ... J Clin Oncol 28 (16), 2784-2795, 2010 | 4408* | 2010 |
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer AC Wolff, MEH Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ... Archives of pathology & laboratory medicine 131 (1), 18-43, 2007 | 3290 | 2007 |
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer AC Wolff, MEH Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ... Archives of pathology & laboratory medicine 131 (1), 18-43, 2007 | 3290 | 2007 |
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer AC Wolff, MEH Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ... Archives of pathology & laboratory medicine 131 (1), 18-43, 2007 | 3290 | 2007 |
| Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring … A Rhodes, B Jasani, DM Barnes, LG Bobrow, KD Miller Journal of clinical pathology 53 (2), 125-130, 2000 | 388 | 2000 |
| Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving … A Rhodes, B Jasani, E Anderson, AR Dodson, AJ Balaton American journal of clinical pathology 118 (3), 408-417, 2002 | 213 | 2002 |
| Best Practice No 176: Updated recommendations for HER2 testing in the UK IO Ellis, J Bartlett, M Dowsett, S Humphreys, B Jasani, K Miller, SE Pinder, ... Journal of clinical pathology 57 (3), 233-237, 2004 | 212 | 2004 |
| Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity … A Rhodes, B Jasani, AJ Balaton, DM Barnes, KD Miller Journal of clinical pathology 53 (9), 688-696, 2000 | 205 | 2000 |
| Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe: documentation of poor reliability and identification of … A Rhodes, B Jasani, AJ Balaton, DM Barnes, E Anderson, LG Bobrow, ... American journal of clinical pathology 115 (1), 44-58, 2001 | 193 | 2001 |
| Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality … A Rhodes, B Jasani, AJ Balaton, KD Miller Journal of clinical pathology 53 (4), 292-301, 2000 | 168 | 2000 |
| A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer A Rhodes, B Jasani, J Couturier, MJ McKinley, JM Morgan, AR Dodson, ... American journal of clinical pathology 117 (1), 81-89, 2002 | 115 | 2002 |
| Antigen unmasking in formalin-fixed routinely processed paraffin wax-embedded sections by pressure cooking: a comparison with microwave oven heating and traditional methods K Miller, J Auld, E Jessup, A Rhodes, M Ashton-Key Advances in Anatomic Pathology 2 (1), 60-64, 1995 | 83 | 1995 |
| Estrogen and progesterone receptors in breast cancer CH Yip, A Rhodes Future Oncology 10 (14), 2293-2301, 2014 | 82 | 2014 |
| Pathology reporting of breast disease IO Ellis, SE Pinder, L Bobrow, ID Buley, J Coyne, JJ Going, S Humphreys, ... NHS publication, 2005 | 73 | 2005 |
| Comparison of breast cancer in Indonesia and Malaysia–A clinico-pathological study between Dharmais cancer centre Jakarta and University Malaya Medical Centre, Kuala Lumpur A Rhodes, C Yip Asian Pacific Journal of Cancer Prevention 12, 2943-2946, 2011 | 65 | 2011 |
| Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer SJR Dean, CM Perks, JMP Holly, N Bhoo-Pathy, LM Looi, ... American Journal of Clinical Pathology 141 (3), 323-333, 2014 | 55 | 2014 |
| Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer … SY Phuah, LM Looi, N Hassan, A Rhodes, S Dean, NAM Taib, CH Yip, ... Breast Cancer Research 14 (6), 1-9, 2012 | 55 | 2012 |
| The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact? A Rhodes, B Jasani Journal of clinical pathology 62 (1), 95-96, 2009 | 43 | 2009 |
| The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more … A Rhodes, D Borthwick, R Sykes, S Al-Sam, A Paradiso American journal of clinical pathology 122 (1), 51-60, 2004 | 43 | 2004 |
